Matthew is a dynamic litigator with a concentrated practice in products liability, toxic torts, e-discovery, and multi-district litigation. Known for his ability to translate complex medical, scientific, and technical concepts into persuasive and digestible narratives, Matthew provides his knowledge and helps shape overarching trial themes that resonate in the courtroom. He has served as a...
Matthew is a dynamic litigator with a concentrated practice in products liability, toxic torts, e-discovery, and multi-district litigation. Known for his ability to translate complex medical, scientific, and technical concepts into persuasive and digestible narratives, Matthew provides his knowledge and helps shape overarching trial themes that resonate in the courtroom. He has served as a member of several trial teams for national-level litigation, often assisting trial teams in their presentation of the overall medical, scientific, and technical evidence into jury-friendly trial themes. Matthew has also taken many expert depositions in one of the largest multidistrict litigations in history and even secured exclusions of experts under Daubert resulting in complete dismissals on summary judgment.
member of several trial teams for national-level litigation, often assisting trial teams in their presentation of the overall medical, scientific, and technical evidence into jury-friendly trial themes. Matthew has also taken many expert depositions in one of the largest multidistrict litigations in history and even secured exclusions of experts under Daubert resulting in complete dismissals on summary judgment.
How Cos. Should Handle Research Org.'s Carcinogen Evals, Law360, Co-Author (July 23, 2024) |
IARC Releases Its 2025- 2029 Priority List For Evaluation, Defense Research Institute Magazine, Co-Author (July & August Edition) |
Preventing the Professional’s Impossible Choice: Paving the Path for Recognizing Ethical Codes as Public Policy in the Context of Wrongful Discharge in South Carolina, 73 S.C. L. REV. 1021, Author (2022) |
“The Kids are Alright: Addressing the Professional’s Impossible Choice in South Carolina”, Employment Law Mid-year CLE 2025, Presenter and Panelist (May 16, 2025) |
IARC Releases Its Priority Evaluation List for 2025-2029, The Life Sciences Lab, Author (Sept. 11, 2024) |
Matthew is a dynamic litigator with a concentrated practice in products liability, toxic torts, e-discovery, and multi-district litigation. Known for his ability to translate complex medical, scientific, and technical concepts into persuasive and digestible narratives, Matthew provides his knowledge and helps shape overarching trial themes that resonate in the courtroom. He has served as a... member of several trial teams for national-level litigation, often assisting trial teams in their presentation of the overall medical, scientific, and technical evidence into jury-friendly trial themes. Matthew has also taken many expert depositions in one of the largest multidistrict litigations in history and even secured exclusions of experts under Daubert resulting in complete dismissals on summary judgment.
How Cos. Should Handle Research Org.'s Carcinogen Evals, Law360, Co-Author (July 23, 2024) |
IARC Releases Its 2025- 2029 Priority List For Evaluation, Defense Research Institute Magazine, Co-Author (July & August Edition) |
Preventing the Professional’s Impossible Choice: Paving the Path for Recognizing Ethical Codes as Public Policy in the Context of Wrongful Discharge in South Carolina, 73 S.C. L. REV. 1021, Author (2022) |
“The Kids are Alright: Addressing the Professional’s Impossible Choice in South Carolina”, Employment Law Mid-year CLE 2025, Presenter and Panelist (May 16, 2025) |
IARC Releases Its Priority Evaluation List for 2025-2029, The Life Sciences Lab, Author (Sept. 11, 2024) |